Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss

J Clin Oncol. 2012 Nov 20;30(33):e356-7. doi: 10.1200/JCO.2011.41.4359. Epub 2012 Oct 8.

Authors

Caroline Voskens¹, Alexander Cavallaro, Michael Erdmann, Olga Dippel, Eckhart Kaempgen, Gerold Schuler, Beatrice Schuler-Thurner, Lucie Heinzerling

Affiliation

¹ University Hospital Erlangen, Erlangen, Germany.

PMID: 23045571
DOI: 10.1200/JCO.2011.41.4359

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Blindness / etiology
Blindness / immunology
CTLA-4 Antigen / immunology*
Female
Hearing Loss / etiology
Humans
Ipilimumab
Melanoma / drug therapy*
Melanoma / immunology
Melanoma / secondary*
Middle Aged
Pneumonia, Mycoplasma / etiology
Renal Insufficiency / etiology
Renal Insufficiency / immunology
Spinal Cord Neoplasms / complications
Spinal Cord Neoplasms / drug therapy*
Spinal Cord Neoplasms / pathology
Spinal Cord Neoplasms / secondary*
T-Lymphocytes, Cytotoxic / immunology

Substances

Antibodies, Monoclonal
CTLA-4 Antigen
Ipilimumab